SUMMIT refers to tirzepatide studies, not retatrutide
Irregular dosing reduces the medications effectiveness for weight loss and may increase side effects when you resume
In addition, family members can begin the healing process from the often painful or traumatic challenges of the individuals addiction

Studies show that without ongoing medication: Most patients regain 75-90% of lost weight within two years Many report unusually strong hunger signals after discontinuation Metabolic adaptation makes weight maintenance significantly more challenging Of all the potential long-term effects, bone health deserves special attention because: Bone loss occurs silently : Unlike digestive side effects that are immediately noticeable, bone loss happens gradually with no symptoms until a fracture occurs The effects can be permanent : Once significant bone loss occurs, it can be difficult to fully restore The consequences are serious : Osteoporotic fractures can lead to chronic pain, disability, and in the case of hip fractures, a 20-30% mortality rate in the first year Combination risk factors : Many people taking GLP-1 medications already have other risk factors for osteoporosis, creating a perfect storm for bone health problems Also read: Does Ozempic Cause Osteoporosis

Technical considerations include proper patient positioning in right lateral decubitus, antral cross-sectional area measurement, and qualitative assessment categorising gastric contents as empty, clear fluid, or thick fluid/solids [60]
If you are also interested in how expiration affects other GLP-1 medications, the tirzepatide expiration guide and the expired tirzepatide guide cover similar territory for that medication